NGL Fine-Chem Limited (NGLFINE.NS)

INR 1072.8

(-1.93%)

Total Assets Summary of NGL Fine-Chem Limited

  • NGL Fine-Chem Limited's latest annual total assets in 2023 was 3.55 Billion INR , up 23.85% from previous year.
  • NGL Fine-Chem Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • NGL Fine-Chem Limited reported annual total assets of 2.87 Billion INR in 2022, up 3.67% from previous year.
  • NGL Fine-Chem Limited reported annual total assets of 2.76 Billion INR in 2021, up 33.29% from previous year.
  • NGL Fine-Chem Limited reported quarterly total assets of 3.55 Billion INR for 2023 Q4, down 0.0% from previous quarter.
  • NGL Fine-Chem Limited reported quarterly total assets of - INR for 2023 Q3, down -100.0% from previous quarter.

Annual Total Assets Chart of NGL Fine-Chem Limited (2023 - 2008)

Historical Annual Total Assets of NGL Fine-Chem Limited (2023 - 2008)

Year Total Assets Total Assets Growth
2023 3.55 Billion INR 23.85%
2022 2.87 Billion INR 3.67%
2021 2.76 Billion INR 33.29%
2020 2.07 Billion INR 35.25%
2019 1.53 Billion INR 8.04%
2018 1.42 Billion INR 9.98%
2017 1.29 Billion INR 27.69%
2016 1.01 Billion INR 30.63%
2015 775.06 Million INR 16.52%
2014 665.17 Million INR 19.11%
2013 558.45 Million INR 17.83%
2012 473.96 Million INR 27.44%
2011 371.9 Million INR 13.2%
2010 328.52 Million INR 29.53%
2009 253.63 Million INR 24.59%
2008 203.57 Million INR 0.0%

Peer Total Assets Comparison of NGL Fine-Chem Limited

Name Total Assets Total Assets Difference
Abbott India Limited 51.93 Billion INR 93.154%
Cipla Limited 327.17 Billion INR 98.913%
Gland Pharma Limited 106.61 Billion INR 96.665%
GlaxoSmithKline Pharmaceuticals Limited 35.73 Billion INR 90.051%
Kopran Limited 7.43 Billion INR 52.164%
Marksans Pharma Limited 26.8 Billion INR 86.738%
Pfizer Limited 42.28 Billion INR 91.592%
Sanofi India Limited 17.14 Billion INR 79.267%
SMS Pharmaceuticals Limited 10.34 Billion INR 65.619%
TTK Healthcare Limited 12 Billion INR 70.387%